β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights (2) π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
| Date accepted | Link | Final link |
|---|---|---|
| 2026-06-08 09:49:23 | 6-K | 6-K final |
| 2026-06-01 07:53:01 | 6-K | 6-K final |
| 2026-05-27 06:00:08 | 6-K | 6-K final |
| 2026-05-22 14:32:50 | 6-K | 6-K final |
| 2026-05-22 12:29:54 | SD | SD final |
| 2026-05-22 10:01:32 | ***** | ***** |
| 2026-05-18 10:29:05 | ***** | ***** |
| 2026-05-13 07:53:54 | ***** | ***** |
| 2026-05-06 07:51:16 | ***** | ***** |
| 2026-05-05 09:30:07 | ***** | ***** |
| 2026-04-27 07:21:33 | ***** | ***** |
| 2026-04-20 09:38:24 | ***** | ***** |
| 2026-04-20 06:50:08 | ***** | ***** |
| 2026-04-13 07:52:08 | ***** | ***** |
| 2026-04-10 08:30:20 | ***** | ***** |
π Explore more SEC filings for Novo Nordisk!
Sign up for free or log inπ Unlock our free guide: "The Checklist Value Investor β A Smarter Way to Pick Stocks"